Related Experiment Video

Updated: Jun 6, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

Risk stratification in patients with chronic heart failure based on metabolic-immunological, functional and

Ralph Herrmann1, Anja Sandek, Stephan von Haehling

  • 1Department of Cardiology, Charité Medical School, Campus Virchow-Klinikum, Berlin, Germany.

International Journal of Cardiology
|November 25, 2010
PubMed

Insights

Predicting chronic heart failure (CHF) mortality is challenging. New metabolic and immunological markers like uric acid and sTNF-R1, alongside peak oxygen consumption (pVO2), offer improved risk stratification for CHF patients.

Area of Science:

  • Cardiology
  • Biomarkers
  • Prognostics

Background:

  • Predicting mortality in chronic heart failure (CHF) is crucial but challenging due to limitations of current parameters.
  • Existing clinical parameters often face economic and availability constraints in practice.

Purpose of the Study:

  • To evaluate the prognostic value of serum uric acid, total cholesterol, and soluble tumor necrosis factor receptor 1 (sTNF-R1) in predicting mortality in CHF patients.
  • To compare the predictive performance of these metabolic-immunological markers with established parameters like left ventricular ejection fraction (LVEF) and peak oxygen consumption (pVO2).

Main Methods:

  • Prospective study of 114 CHF patients (mean age 63.0 ± 1.0 years) with varying NYHA functional classes.
  • Assessment of serum uric acid, total cholesterol, sTNF-R1, LVEF, and pVO2.
  • 24-month follow-up for mortality, analyzed using Cox proportional hazard models and ROC curve analysis.

Main Results:

  • Serum uric acid, total cholesterol, sTNF-R1, LVEF, and pVO2 all significantly predicted survival in CHF patients.
  • Uric acid and sTNF-R1 demonstrated prognostic performance comparable to pVO2 and superior to LVEF.
  • A combined model including pVO2, LVEF, uric acid, and sTNF-R1 achieved the highest prognostic value (AUC: 0.91).

Conclusions:

  • Metabolic-immunological parameters significantly enhance risk stratification in CHF compared to clinical parameters alone.
  • These markers may better reflect the multisystem nature of CHF.
  • Further validation in larger populations is recommended for these promising biomarkers.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...